The drug is still in the trial phase.

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be great ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." In a perfect world, you’d lose fat while keeping your muscle mass intact. Unfortunately, it’s common for ...

Weight loss drugs have soared in popularity in the past year, helping some lose dramatic amounts of weight — but not all that weight is fat. Some of that is actually lean mass, which is everything in ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? There are two drugs, currently in clinical trials, aiming to help patients ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass. The medication just went through phase 1 clinical trials. Doctors explain the new medication and ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

University of Utah Health researchers have discovered that Metformin, a common drug that’s been used in diabetes treatment for more than half a century, has surprising applications on a cellular level ...

Gym chains, nutrition startups and drugmakers all want to solve a common issue among people who take weight loss drugs. By Dani Blum As drugs like Ozempic become increasingly popular for weight loss, ...